HMGB1 and B-cell chronic lymphocytic leukemia: The magnitude of extracellular HMGB1 released from HG-3 and OSU-CLL cells due to therapeutic stress was monitored after 24 h (Figure 3A,C) and 48 h (Figure 3B,D) treatment periods by measuring HMGB1-associated bioluminescence.